Current dogma suggests that the positive correlation between obesity and cancer is driven by white adipose tissue that accompanies obesity, possibly through excess secretion of adipokines. Recent studies in fatless A-Zip/F1 mice, which have undetectable adipokine levels but display accelerated tumor formation, suggest that adipokines are not required for the enhanced tumor development. The A-Zip/F-1 mice are also diabetic and display elevated circulating levels of other factors frequently associated with obesity (insulin, insulin-like growth factor-1, and proinflammatory cytokines) and activation of several signaling pathways associated with carcinogenesis. In view of this information, the risk factors underlying the obesity-cancer link need to be revisited. We postulate that the pathways associated with insulin resistance and inflammation, rather than adipocyte-derived factors, may represent key prevention and therapeutic targets for disrupting the obesity-cancer link. ©2007 American Association for Cancer Research.
CITATION STYLE
Hursting, S. D., Nunez, N. P., Varticovski, L., & Vinson, C. (2007, March 15). The obesity-cancer link: Lessons learned from a fatless mouse. Cancer Research. https://doi.org/10.1158/0008-5472.CAN-06-4237
Mendeley helps you to discover research relevant for your work.